Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Biomarker Assessment of Glutamatergic Target Engagement


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02134951

Organisation Name: New York State Psychiatric Institute

Overal Status: Completed

Start Date: May 2014

Last Update: August 17, 2018

Lead Sponsor: New York State Psychiatric Institute

Brief Summary: The purpose of this study is to assess the relative feasibility of 2 potential functional measures of target engagement (Glx MRS, BOLD fMRI) to systematically assess mGluR 2/3 in drug development for psychotic spectrum disorders.

Conditions:
  • Healthy Controls


Total execution time in seconds: 0.16047120094299